NCT03806348

Brief Summary

Women who deliver their baby vaginally often suffer from a perineal wound. The wound is after being sutured sometimes dehisced after days up to a few weeks and this study will investigate whether it is better to resuture early or leave the rupture for secondary healing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

December 12, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 16, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

January 16, 2019

Status Verified

January 1, 2019

Enrollment Period

2.1 years

First QC Date

November 29, 2018

Last Update Submit

January 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Need of late perineal reconstruction

    Digital palpation of the perineal body and assessment of thickness. POP-Q score; nine points in the vagina are identified. The hymen is the reference point to which the other points are compared. The prolapsed organs are measured in centimeters to the hymen. The measurements are taken when the Valsalva maneuver is performed by the woman. Anovaginal distance using perineal ultrasound. Validated scales to identify specific symptoms from the perineum and to identify the feeling of vaginal wideness and the need for digital assistance during defecation. PFDI 20- short form-version of pelvic floor distress inventory FSFI - female sexual function index PFIQ - pelvic floor impact questionnaire

    One year

Secondary Outcomes (11)

  • Pelvic floor symptoms and the impact on quality of life

    One year

  • Pelvic floor symptoms and the impact on quality of life

    One year

  • Sexual function

    One year

  • Wound healing

    2 weeks

  • Wound healing

    4 weeks

  • +6 more secondary outcomes

Study Arms (2)

Resuturing

EXPERIMENTAL

Early resuturing of perineal wound dehiscence. Antibiotics: Amoxicillin 500 mg, Clavulanic Acid 125 mg and Metronidazole 400 mg by mouth, every 8 hours, for at least 6 Days.

Procedure: Resuturing

Conservative treatment

NO INTERVENTION

Antibiotics: Amoxicillin 500 mg, Clavulanic Acid 125 mg and Metronidazole 400 mg by mouth, every 8 hours, for at least 6 Days.

Interventions

ResuturingPROCEDURE

Early reconstruction of the perineal body after wound dehiscence within two weeks of delivery.

Resuturing

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman over 18 years old who had a vaginal delivery and suffered from a perineal rupture, grade 2 (spontaneous or episiotomy).
  • No longer than two weeks has passed since delivery.
  • The woman must be able to give informed consent.

You may not qualify if:

  • Perineal rupture grade 3 and 4.
  • Woman suffering from connective tissue disease.
  • Ongoing treatment with oral cortisone or other immunosuppressive disease.
  • Diabetes treated with insulin.
  • Suspicion of occult damage of the anal sphincter.
  • Earlier surgery of the perineum.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, Stockholm South General Hospital

Stockholm, 11883, Sweden

RECRUITING

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Marion Ek, PhD, MD

    Department of Obstetrics and Gynecology, Stockholm South General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant

Study Record Dates

First Submitted

November 29, 2018

First Posted

January 16, 2019

Study Start

December 12, 2018

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

January 16, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations